|
| 36926036 | Four missense genetic variants in <i>CUBN</i> are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans. | Front Endocrinol (Lausanne) | 2023 |
| 37834292 | Apolipoprotein-CIII <i>O</i>-Glycosylation, a Link between <i>GALNT2</i> and Plasma Lipids. | Int J Mol Sci | 2023 |
| 37589137 | Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease. | Arterioscler Thromb Vasc Biol | 2023 |
| 37913561 | Identifying lipid traces of atherogenic mechanisms in human carotid plaque. | Atherosclerosis | 2023 |
| 37082982 | Lipoprotein(a) is associated with a larger systemic burden of arterial calcification. | Eur Heart J Cardiovasc Imaging | 2023 |
| 37022971 | Heart Rate Variability and Incident Type 2 Diabetes in General Population. | J Clin Endocrinol Metab | 2023 |
| 37126315 | Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands. | JAMA Pediatr | 2023 |
| 36990054 | Associations of baseline glycemic status and its transitions with cognitive and physical functioning decline. | Maturitas | 2023 |
| 36926036 | Four missense genetic variants in <i>CUBN</i> are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans. | Front Endocrinol (Lausanne) | 2023 |
| 37220621 | Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of <i>APOE4</i> Homozygotes and Non-<i>APOE4</i> Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline. | J Alzheimers Dis Rep | 2023 |
| 37913561 | Identifying lipid traces of atherogenic mechanisms in human carotid plaque. | Atherosclerosis | 2023 |
| 37589137 | Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease. | Arterioscler Thromb Vasc Biol | 2023 |
| 37834292 | Apolipoprotein-CIII <i>O</i>-Glycosylation, a Link between <i>GALNT2</i> and Plasma Lipids. | Int J Mol Sci | 2023 |
| 37126315 | Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands. | JAMA Pediatr | 2023 |
| 37220621 | Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of <i>APOE4</i> Homozygotes and Non-<i>APOE4</i> Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline. | J Alzheimers Dis Rep | 2023 |
| 37022971 | Heart Rate Variability and Incident Type 2 Diabetes in General Population. | J Clin Endocrinol Metab | 2023 |
| 36990054 | Associations of baseline glycemic status and its transitions with cognitive and physical functioning decline. | Maturitas | 2023 |
| 37082982 | Lipoprotein(a) is associated with a larger systemic burden of arterial calcification. | Eur Heart J Cardiovasc Imaging | 2023 |
| 34906454 | The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification. | Genet Med | 2022 |
| 35869873 | Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification. | Eur Heart J | 2022 |
| 36556425 | Mortality in Pedigrees with Acute Intermittent Porphyria. | Life (Basel) | 2022 |
| 34906454 | The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification. | Genet Med | 2022 |
| 34889083 | A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP-1 dual agonist. | CPT Pharmacometrics Syst Pharmacol | 2022 |
| 36556425 | Mortality in Pedigrees with Acute Intermittent Porphyria. | Life (Basel) | 2022 |
| 35869873 | Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification. | Eur Heart J | 2022 |
| 34889083 | A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP-1 dual agonist. | CPT Pharmacometrics Syst Pharmacol | 2022 |
| 34026735 | Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry. | Front Chem | 2021 |
| 36644668 | Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus. | Atheroscler Plus | 2021 |
| 33963048 | Lipoprotein(a) is robustly associated with aortic valve calcium. | Heart | 2021 |
| 33625129 | Sharing ICU Patient Data Responsibly Under the Society of Critical Care Medicine/European Society of Intensive Care Medicine Joint Data Science Collaboration: The Amsterdam University Medical Centers Database (AmsterdamUMCdb) Example. | Crit Care Med | 2021 |
| 34026735 | Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry. | Front Chem | 2021 |
| 34245042 | Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study. | Diabet Med | 2021 |
| 34859676 | Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring. | Anal Chem | 2021 |
| 34776936 | Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control Mice. | Front Aging Neurosci | 2021 |
| 34656955 | The effect of monomeric and oligomeric FLAVAnols in patients with type 2 diabetes and microalbuminuria (FLAVA-trial): A double-blind randomized controlled trial. | Clin Nutr | 2021 |
| 34645615 | Plasma protein <i>N-</i>glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes. | BMJ Open Diabetes Res Care | 2021 |
| 36644668 | Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus. | Atheroscler Plus | 2021 |
| 33625129 | Sharing ICU Patient Data Responsibly Under the Society of Critical Care Medicine/European Society of Intensive Care Medicine Joint Data Science Collaboration: The Amsterdam University Medical Centers Database (AmsterdamUMCdb) Example. | Crit Care Med | 2021 |
| 34859676 | Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring. | Anal Chem | 2021 |
| 34645615 | Plasma protein <i>N-</i>glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes. | BMJ Open Diabetes Res Care | 2021 |
| 34776936 | Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control Mice. | Front Aging Neurosci | 2021 |
| 34656955 | The effect of monomeric and oligomeric FLAVAnols in patients with type 2 diabetes and microalbuminuria (FLAVA-trial): A double-blind randomized controlled trial. | Clin Nutr | 2021 |
| 34245042 | Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study. | Diabet Med | 2021 |
| 33963048 | Lipoprotein(a) is robustly associated with aortic valve calcium. | Heart | 2021 |
| 32349995 | Association of the IgG <i>N</i>-glycome with the course of kidney function in type 2 diabetes. | BMJ Open Diabetes Res Care | 2020 |
| 32433470 | Anxiety and depression in diabetes care: longitudinal associations with health-related quality of life. | Sci Rep | 2020 |
| 32379398 | Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study. | Obesity (Silver Spring) | 2020 |
| 32078427 | Letter by Weingärtner et al Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial". | Circulation | 2020 |
| 32025877 | Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study. | Acta Diabetol | 2020 |
| 31895451 | Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older. | JAMA Cardiol | 2020 |